10-Q 1 d10q.htm FORM 10-Q Form 10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 


 

FORM 10-Q

 


 

(Mark One)

x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended December 30, 2005

 

OR

 

¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from              to             

 

Commission file number 1-5517

 


 

SCIENTIFIC-ATLANTA, INC.

(Exact name of Registrant as specified in its charter)

 


 

Georgia   58-0612397

(State or other jurisdiction of

incorporation or organization)

 

(I.R.S. Employer

Identification Number)

5030 Sugarloaf Parkway

Lawrenceville, Georgia

  30044-2869
(Address of principal executive offices)   (Zip Code)

 

770-236-5000

(Registrant’s telephone number, including area code)

 


 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  x    No  ¨

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, or a non-accelerated filer. See definition of “accelerated filer and large accelerated filer” in Rule 12b-2 of the Exchange Act (Check one):

Large accelerated filer  x    Accelerated filer  ¨    Non-accelerated filer  ¨

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes  ¨    No  x

 

As of January 27, 2006, Scientific-Atlanta, Inc. had outstanding 154,827,972 shares of common stock.

 



PART I - FINANCIAL INFORMATION

 

SCIENTIFIC-ATLANTA, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF EARNINGS

(IN THOUSANDS, EXCEPT PER SHARE DATA)

(UNAUDITED)

 

     Three Months Ended

    Six Months Ended

 
    

December 30,

2005


   

December 31,

2004


   

December 30,

2005


   

December 31,

2004


 

SALES

   $ 495,241     $ 441,672     $ 985,289     $ 894,346  
    


 


 


 


COSTS AND EXPENSES

                                

Cost of sales

     316,299       277,951       622,673       564,826  

Sales and administrative

     64,210       47,893       121,302       96,654  

Research and development

     40,352       37,881       84,613       76,222  

Restructuring

     302       (8 )     1,197       (12 )

Interest expense

     93       174       363       331  

Interest income

     (12,529 )     (6,765 )     (23,163 )     (12,539 )

Other income, net

     3,051       1,020       3,027       855  
    


 


 


 


Total costs and expenses

     411,778       358,146       810,012       726,337  
    


 


 


 


EARNINGS BEFORE INCOME TAXES

     83,463       83,526       175,277       168,009  

PROVISION FOR (BENEFIT FROM) INCOME TAXES

                                

Current

     34,791       23,925       66,229       56,632  

Deferred

     (4,775 )     908       (5,143 )     (3,194 )
    


 


 


 


NET EARNINGS

   $ 53,447     $ 58,693     $ 114,191     $ 114,571  
    


 


 


 


EARNINGS PER COMMON SHARE

                                

BASIC

   $ 0.35     $ 0.39     $ 0.74     $ 0.75  
    


 


 


 


DILUTED

   $ 0.34     $ 0.38     $ 0.74     $ 0.74  
    


 


 


 


WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING

                                

BASIC

     153,956       152,395       153,605       152,913  
    


 


 


 


DILUTED

     155,862       154,510       155,338       154,973  
    


 


 


 


DIVIDENDS PER SHARE PAID

   $ 0.01     $ 0.01     $ 0.02     $ 0.02  
    


 


 


 


 

SEE ACCOMPANYING NOTES

 

2


SCIENTIFIC-ATLANTA, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF FINANCIAL POSITION

(IN THOUSANDS, EXCEPT SHARE DATA)

(UNAUDITED)

 

    

December 30,

2005


  

July 1,

2005


ASSETS

             

CURRENT ASSETS

             

Cash and cash equivalents

   $ 584,836    $ 475,529

Short-term investments

     1,063,926      1,046,091

Receivables, less allowance for doubtful accounts of $2,958 at December 30 and $3,038 at July 1

     270,672      243,509

Inventories

     139,118      129,070

Deferred income taxes

     32,270      31,381

Other current assets

     26,328      32,116
    

  

TOTAL CURRENT ASSETS

     2,117,150      1,957,696
    

  

PROPERTY, PLANT AND EQUIPMENT, at cost

             

Land and improvements

     24,702      24,715

Buildings and improvements

     116,762      115,587

Machinery and equipment

     226,299      215,602
    

  

       367,763      355,904

Less - Accumulated depreciation and amortization

     160,477      142,366
    

  

       207,286      213,538

GOODWILL

     218,529      217,938

INTANGIBLE ASSETS

     19,260      24,048

DEFERRED INCOME TAXES

     62,830      57,173

OTHER ASSETS

     121,879      119,440
    

  

TOTAL ASSETS

   $ 2,746,934    $ 2,589,833
    

  

LIABILITIES AND STOCKHOLDERS’ EQUITY

             

CURRENT LIABILITIES

             

Current maturities of long-term debt

   $ 1,212    $ 1,230

Accounts payable

     179,898      194,633

Accrued liabilities

     124,776      138,120

Deferred revenue

     20,476      13,735

Income taxes currently payable

     14,083      13,071
    

  

TOTAL CURRENT LIABILITIES

     340,445      360,789
    

  

LONG-TERM DEBT, LESS CURRENT MATURITIES

     5,580      6,240

NON-CURRENT DEFERRED REVENUE

     11,907      9,262

OTHER LIABILITIES

     238,531      232,582

STOCKHOLDERS’ EQUITY

             

Preferred stock, authorized 50,000,000 shares; no shares issued

     —        —  

Common stock, $0.50 par value, authorized 350,000,000 shares; issued 164,992,376 shares at December 30 and July 1

     82,496      82,496

Additional paid-in capital

     597,362      568,149

Retained earnings

     1,608,630      1,500,430

Accumulated other comprehensive income, net of taxes of $11,262 at December 30 and $12,525 at July 1

     28,329      30,073
    

  

       2,316,817      2,181,148

Less - Treasury stock, at cost (10,707,594 shares at December 30 and 12,138,605 at July 1)

     166,346      200,188
    

  

       2,150,471      1,980,960
    

  

TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY

   $ 2,746,934    $ 2,589,833
    

  

 

SEE ACCOMPANYING NOTES

 

3


SCIENTIFIC-ATLANTA, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(IN THOUSANDS)

(UNAUDITED)

 

     Six Months Ended

 
     December 30,
2005


    December 31,
2004


 

NET CASH PROVIDED BY OPERATING ACTIVITIES

   $ 121,381     $ 130,083  
    


 


INVESTING ACTIVITIES:

                

Purchases of short-term investments

     (528,233 )     (803,561 )

Proceeds from sales of short-term investments

     506,025       722,979  

Purchases of property, plant, and equipment

     (16,670 )     (58,071 )

Acquisition of Scientific-Atlanta of Shanghai, Ltd., net of cash received

     (1,583 )     —    

Other

     —         157  
    


 


Net cash used in investing activities

     (40,461 )     (138,496 )
    


 


FINANCING ACTIVITIES:

                

Purchases of common stock

     —         (50,703 )

Issuance of common stock from treasury

     27,908       5,049  

Dividends paid

     (3,071 )     (3,052 )

Excess tax benefit on stock option exercises

     4,163       —    

Principal payments on debt

     (613 )     (625 )
    


 


Net cash provided by (used in) financing activities

     28,387       (49,331 )
    


 


INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS

     109,307       (57,744 )

CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD

     475,529       285,106  
    


 


CASH AND CASH EQUIVALENTS AT END OF PERIOD

   $ 584,836     $ 227,362  
    


 


SUPPLEMENTAL CASH FLOW DISCLOSURES

                

Cash paid during the period:

                

Interest

   $ 307     $ 296  
    


 


Income taxes paid, net

   $ 52,193     $ 37,147  
    


 


 

4


SCIENTIFIC-ATLANTA, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

(IN THOUSANDS)

(UNAUDITED)

 

     Three Months Ended

    Six Months Ended

 
     December 31,
2005


    December 30,
2004


    December 31,
2005


    December 30,
2004


 

NET EARNINGS

   $ 53,447     $ 58,693     $ 114,191     $ 114,571  

OTHER COMPREHENSIVE INCOME, NET OF TAX (1)

                                

Net foreign currency translation adjustments

     (2,676 )     18,229       (1,791 )     19,221  

Net unrealized holding losses on short-term investments

     (147 )     (1,007 )     (235 )     (803 )

Net unrealized holding gains (losses) on available-for-sale marketable securities

     2       (3 )     16       —    

Net change in fair value of derivatives

     (56 )     110       266       377  
    


 


 


 


COMPREHENSIVE INCOME

   $ 50,570     $ 76,022     $ 112,447     $ 133,366  
    


 


 


 



(1) Assumed weighted-average of approximately 40 and 35 percent tax rate in fiscal years 2006 and 2005, respectively.

 

SEE ACCOMPANYING NOTES

 

5


NOTES:

(Amounts in thousands, except share and per share data)

 

  A. The accompanying consolidated financial statements include the accounts of Scientific-Atlanta, Inc. (Scientific-Atlanta) and all subsidiaries after elimination of all material intercompany accounts and transactions. Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States have been condensed or omitted pursuant to the rules and regulations of the Securities and Exchange Commission. These condensed financial statements should be read in conjunction with the consolidated financial statements and related notes contained in our fiscal year 2005 Annual Report on Form 10-K. The financial information presented in the accompanying statements reflects all adjustments which are, in the opinion of management, necessary for a fair presentation of the periods indicated. All such adjustments are of a normal recurring nature, except as noted below.

 

During the third quarter of fiscal year 2005, we began classifying all auction rate securities and variable rate demand obligations as Short-term investments. We have reclassified $112,223 and $157,076 from Cash and cash equivalents to Short-term investments at December 31, 2004 and July 2, 2004, respectively, related to these securities and obligations. The Consolidated Statement of Cash Flows for the six months ended December 31, 2004 has been reclassified to reflect these adjustments.

 

During fiscal year 2005, we also identified certain purchases and proceeds from the sale of investments in cash equivalents which had been improperly classified as purchases and proceeds from the sale of short-term investments in the Consolidated Statement of Cash Flows for the six months ended December 31, 2004. Accordingly, we reduced purchases by $354,688 and proceeds from the sale of short-term investments by $309,835 in the Consolidated Statement of Cash Flows for the six months ended December 31, 2004 for the reclassifications discussed above. The reclassification of certain purchases and proceeds from the sale of investments in cash equivalents had no impact on net cash used in investing activities in the six months ended December 31, 2004.

 

  B. In November 2005, we announced an agreement to be acquired by Cisco Systems, Inc. (Cisco). On February 2, 2006, the shareholders of the company approved the acquisition at a special meeting of the shareholders. The companies expect the transaction to be consummated in the first quarter of calendar year 2006.

 

6


  C. Basic earnings per share were computed based on the weighted average number of shares of common stock outstanding. Diluted earnings per share were computed based on the weighted average number of outstanding common shares and potentially dilutive shares.

 

Basic and diluted earnings per share are computed as follows:

 

     In Thousands

  

Per Share

Amount


 

Three Months Ended December 30, 2005


  

Net

Earnings


   Shares

  

Basic earnings per common share

   $ 53,447    153,956    $ 0.35  

Effect of dilutive stock options

     —      1,906      (0.01 )
    

  
  


Diluted earnings per common share

   $ 53,447    155,862    $ 0.34  
    

  
  


     In Thousands

  

Per Share

Amount


 

Three Months Ended December 31, 2004


  

Net

Earnings


   Shares

  

Basic earnings per common share

   $ 58,693    152,395    $ 0.39  

Effect of dilutive stock options

     —      2,115      (0.01 )
    

  
  


Diluted earnings per common share

   $ 58,693    154,510    $ 0.38  
    

  
  


     In Thousands

  

Per Share

Amount


 

Six Months Ended December 30, 2005


  

Net

Earnings


   Shares

  

Basic earnings per common share

   $ 114,191    153,605    $ 0.74  

Effect of dilutive stock options

     —      1,733      —    
    

  
  


Diluted earnings per common share

   $ 114,191    155,338    $ 0.74  
    

  
  


     In Thousands

  

Per Share

Amount


 

Six Months Ended December 31, 2004


  

Net

Earnings


   Shares

  

Basic earnings per common share

   $ 114,571    152,913    $ 0.75  

Effect of dilutive stock options

     —      2,060      (0.01 )
    

  
  


Diluted earnings per common share

   $ 114,571    154,973    $ 0.74  
    

  
  


 

 

7


 

The following information pertains to options to purchase shares of common stock which were not included in the computation of diluted earnings per common share because the option’s exercise price was greater than the average market price of the common shares:

 

     December 30,
2005


   December 31,
2004


Number of options outstanding

     8,066,407      11,804,216

Weighted average exercise price

   $ 53.34    $ 47.39
  D. Effective July 2, 2005, we adopted Statement of Financial Accounting Standards (SFAS) No. 123R’s, “Share-Based Payment,” fair value method using its modified prospective transition method. Under this transition method, compensation cost recognized after adoption includes: a) compensation cost for all share-based payments granted prior to, but not yet vested as of July 2, 2005, based on the grant date fair value estimated in accordance with the original provisions of SFAS No. 123, “Accounting for Stock-Based Compensation,” and b) compensation cost for all share-based payments granted subsequent to July 2, 2005, based on the grant-date fair value estimated in accordance with the provisions of SFAS No. 123R. Prior to July 2, 2005 as permitted by SFAS No. 123, we accounted for share-based payments to employees using Accounting Principles Board (APB) Opinion No. 25’s, “Accounting for Stock Issued to Employees”, intrinsic value method and, as such, recognized no compensation cost for employee stock options. Results for prior periods have not been restated. The following disclosure shows what our net earnings and earnings per share would have been using the fair value compensation model under SFAS No. 123R for the three and six months ended December 31, 2004:

 

     December 31, 2004

 
    

Three Months

Ended


   

Six Months

Ended


 

Net earnings as reported

   $ 58,693     $ 114,571  

Deduct: Pro forma compensation expense, net of tax

     (6,330 )     (12,768 )
    


 


Pro forma net earnings

   $ 52,363     $ 101,803  
    


 


Earnings per share:

                

Basic

                

As reported

   $ 0.39     $ 0.75  
    


 


Pro forma

   $ 0.34     $ 0.67  
    


 


Diluted

                

As reported

   $ 0.38     $ 0.74  
    


 


Pro forma

   $ 0.34     $ 0.66  
    


 


 

As previously discussed in our Form 10-K for fiscal year 2005, pro forma compensation expense for fiscal year 2005 was adjusted from previously reported amounts to correct for an error in the attribution of compensation expense in the period. The adjustment resulted in an increase in basic and diluted pro forma earnings per share of $0.01 for the three months ended December 31, 2004. For the six months ended December 31, 2004, the adjustment also resulted in increases of $0.02 per share and $0.03 per share for the basic and diluted pro forma earnings per share, respectively.

 

We have historically recognized pro forma stock compensation expense over the explicit vesting period even though there were provisions for acceleration or continued vesting upon retirement under our stock option plans. Under the guidance of SFAS No. 123R, which we adopted in the first quarter of fiscal year 2006, we will recognize stock compensation expense over the period through the date that the employee first becomes eligible to retire and is no longer required to perform service to vest in the award for grants made after the adoption of SFAS No. 123R. After the adoption of SFAS No. 123R, we will continue to recognize stock compensation costs over the explicit vesting period for awards granted prior to the adoption of SFAS No. 123R.

 

 

8


 

Pro forma stock compensation expense and related earnings per share, if we had recognized compensation expense over the period through the date that the employee had first become eligible to retire, would be as follows:

 

     Three Months Ended

    Six Months Ended

 
     December 30,
2005


   December 31,
2004


    December 30,
2005


   December 31,
2004


 

Net earnings as reported

   $ 53,447    $ 58,693     $ 114,191    $ 114,571  

Deduct: Pro forma compensation expense, net of tax

     —        (6,330 )     —        (12,768 )

Add: Adjustment for retirement eligible employees

     2,048      (734 )     4,097      (1,468 )
    

  


 

  


Pro forma net earnings

   $ 55,495    $ 51,629     $ 118,288    $ 100,335  
    

  


 

  


 

The following table shows a comparison of selected line items of the accompanying financial statements for the three and six months ended December 30, 2005 as reported with the effect of adopting SFAS No. 123R on July 2, 2005 and on a pro forma basis if the company had continued to account for stock option compensation as previously required by SFAS No. 123 and APB Opinion No. 25:

 

     Three Months Ended
December 30, 2005


   Six Months Ended
December 30, 2005


     As Reported

   Pro Forma

   As Reported

   Pro Forma

Earnings from continuing operations

   $ 83,463    $ 93,300    $ 175,277    $ 194,786

Earnings before income taxes

   $ 83,463    $ 93,300    $ 175,277    $ 194,786

Net income

   $ 53,447    $ 59,746    $ 114,191    $ 126,901

Net cash provided by operating activities

   $ 93,912    $ 96,422    $ 121,381    $ 125,544

Net cash provided by financing activities

   $ 15,468    $ 12,958    $ 28,387    $ 24,224

Earnings per share

                           

Basic

   $ 0.35    $ 0.39    $ 0.74    $ 0.83

Diluted

   $ 0.34    $ 0.38    $ 0.74    $ 0.82

 

SFAS No. 123R requires that the benefits of tax deductions in excess of recognized compensation cost be reported as a financing cash flow, rather than as an operating cash flow as required under prior guidance. Excess tax benefits of $4,163 were included in cash provided by financing activities for the six months ended December 30, 2005.

 

  E. On December 30, 2005, we had two types of stock option compensation plans, time-based and performance-based, which are described below. The compensation cost that has been recorded in the Consolidated Statements of Earnings for those plans was $9,837 and $19,509 for the three and six months ended December 30, 2005, respectively. The total income tax benefit recognized in the income statement for stock option compensation arrangements was $3,538 and $6,799 for the three and six months ended December 30, 2005, respectively. Stock option compensation cost capitalized as part of software development costs was $268 and $493 for the three and six months ended December 30, 2005, respectively. Stock option compensation cost was not recorded in the Consolidated Statements of Earnings during fiscal year 2005. Therefore, no income tax benefit was recognized for stock option compensation arrangements and no stock option compensation cost was capitalized as part of software development costs during fiscal year 2005.

 

Our 2003 Long-Term Incentive Plan (LTIP Plan), which is shareholder-approved, permits the grant of stock options to employees that are time-based and performance-based for up to 8,000,000 shares of common stock. The Non-Employee Directors Stock Option Plan, which is also shareholder approved, permits the grant of stock options that are time-based to non-employee members of our Board of Directors for up to 1,800,000 shares. Upon option exercise, we generally issue shares from treasury shares.

 

 

9


Time-based Options

 

Option awards are granted with an exercise price equal to the market price of our stock at the date of grant; those option awards generally vest on a graded schedule over 4 years and have 10-year contractual terms. Employees and directors who are eligible to retire, as defined by the plans, and who do retire, continue to vest in their unvested options after retirement under the terms of the plans. In the event of a change of control of Scientific-Atlanta, all options held on the date of the change of control will become immediately exercisable in full, irrespective of the amount of time that has elapsed from the date of the grant. Scientific-Atlanta employees who signed employment agreements in connection with the Cisco merger agreement have agreed that the accelerated vesting and exercisability of outstanding stock options upon a change in control will occur upon completion of the merger rather than upon shareholder approval of the merger. Dividends are not paid on unexercised options.

 

The fair value of each option award is estimated on the date of grant using the Black-Scholes option pricing model that uses the weighted-average assumptions noted in the following table. Expected volatilities are based on the historical volatility of our stock. We believe that historical volatility is the best indicator of future volatility. We also use historical data to estimate the term options are expected to be outstanding and forfeitures of options granted. Separate groups of employees that have similar historical exercise behavior are considered separately for valuation purposes. The risk-free rate for periods within the expected life of the option is based on the U.S. Treasury yield curve in effect at the time of grant. The fair value of option grants with graded vesting is estimated separately for each vesting date. Compensation cost related to these grants is amortized on a straight-line basis over the vesting period of the option from the grant date to the final vesting date using the average fair value.

 

     Three Months Ended

    Six Months Ended

 
     December 30,
2005


    December 31,
2004


    December 30,
2005


    December 31,
2004


 

Time-based Options:

                                

Weighted-average volatility

     52 %     60 %     53 %     65 %

Expected dividends

   $ 0.04     $ 0.04     $ 0.04     $ 0.04  

Expected terms (in years)

     4.7 years       4.7 years       4.7 years       4.8 years  

Risk-free rate

     4.6 %     3.2 %     4.4 %     3.4 %

 

A summary of activity for time-based options as of December 30, 2005, and changes during the six months then ended is as follows:

 

Time-based Options


   Number of
Shares


    Weighted-
Average
Exercise
Price


   Weighted-
Average
Remaining
Contractual
Term


   Aggregate
Intrinsic
Value


Outstanding at July 1, 2005

   20,715,025     $ 35.77            

Granted

   83,000     $ 39.56            

Exercised

   (1,342,484 )   $ 20.75            

Forfeited or expired

   (204,176 )   $ 45.87            
    

                 

Outstanding at December 30, 2005

   19,251,365     $ 36.73    6.1    $ 174,714
    

 

  
  

Vested or expected to vest at December 30, 2005

   18,673,824     $ 36.73    6.1    $ 169,472
    

 

  
  

Exercisable at December 30, 2005

   14,425,203     $ 39.41    5.1    $ 136,497
    

 

  
  

 

The weighted-average grant-date fair value of options granted in the three and six months ended December 30, 2005 was $18.72 and $18.52, respectively; and in the three and six months ended December 31, 2004 was $14.21 and $15.28, respectively. The total intrinsic value of options exercised in the three and six months ended

 

10


December 30, 2005 was $13,810 and $25,226, respectively; and in the three and six months ended December 31, 2004 was $3,182 and $4,282, respectively.

 

Time-based options outstanding at December 30, 2005 include options granted in prior years under the LTIP Plan and other stock option plans whose terms and fair value assumptions are similar to those described above.

 

As of December 30, 2005, there was $50,693 of total unrecognized compensation cost related to nonvested time-based stock options. This cost is expected to be recognized over a weighted-average period of 1.3 years.

 

Performance-based Options

 

Performance-based stock option grants are made to selected executives and other key employees. Vesting of performance-based options granted in the first quarter of fiscal year 2006 is contingent upon achieving compound annual percentage growth in net revenues. Stock options are granted at the market price of our stock at the date of grant; contingently vest over a period of 3 to 10 years, depending on the achievement of the performance goal; and have contractual lives of 10 years. In the event of a change of control of Scientific-Atlanta, all options held on the date of the change of control will become immediately exercisable in full, irrespective of the achievement of the performance goal. Scientific-Atlanta employees who signed employment agreements in connection with the Cisco merger agreement have agreed that the accelerated vesting and exercisability of outstanding stock options upon a change in control will occur upon completion of the merger rather than upon shareholder approval of the merger. Dividends are not paid on unexercised options.

 

The fair value of each performance-based option grant was estimated on the date of grant using the same option valuation model used for time-based options described above and assumes that performance goals will be achieved. If such goals are not met within 10 years from the date of grant, no compensation cost will be recognized; any recognized compensation cost will be reversed; and the options will be forfeited. The inputs for expected volatility, expected dividends, and risk-free rate used in estimating those options’ fair value are shown in the table below. No such options were granted during the three months ended December 30, 2005 or the three months or six months ended December 31, 2004.

 

     Six Months Ended

 
     December 30,
2005


 

Performance-based Options

      

Weighted-average volatility

   69 %

Expected dividends

   0.12 %

Expected terms (in years)

   6.0  

Risk-free rate

   4.0 %

 

 

11


A summary of the activity for performance-based options as of December 30, 2005 and changes during the six months then ended is as follows:

 

Performance-based Options


   Number of
Shares


   Weighted-
Average
Exercise
Price


   Weighted-
Average
Remaining
Contractual
Term


   Aggregate
Intrinsic
Value


Outstanding at July 1, 2005

   1,300,500    $ 21.82            

Granted

   373,500    $ 33.87            

Exercised

   —      $ —              

Forfeited or expired

   —      $ —              
    
                  

Outstanding at December 30, 2005

   1,674,000    $ 24.50    7.7    $ 31,078
    
  

  
  

Vested or expected to vest at December 30, 2005

   1,604,900    $ 24.83    7.7    $ 29,281
    
  

  
  

Exercisable at December 30, 2005

   —        —      —        —  
    
  

  
  

 

The weighted-average grant-date fair value of options granted during the quarter ended September 30, 2005 was $21.68. We expect these options will fully vest. We expense the related compensation cost on a straight-line basis from the date of grant through the expected date of achievement of the performance target. There were no options exercised during the three or six months ended December 30, 2005 or December 31, 2004. As of December 30, 2005, there was $15,949 of total unrecognized compensation cost related to performance-based options. This cost is expected to be recognized over a weighted-average period of 1.4 years.

 

Performance-based options outstanding at December 30, 2005 include options granted in prior years under another shareholder-approved equity incentive plan whose terms and fair value assumptions are similar to those described above. However, options granted under this plan fully vest six years from the date of grant regardless of whether the performance target is achieved. Accordingly, compensation expense for these grants will be recorded regardless of whether the performance target is achieved, provided the requisite service is provided by the employee. We record compensation expense for these grants using the greater of straight-line amortization over six years or the estimated date of achievement of the performance target.

 

Cash received from option exercises during the six months ended December 30, 2005 and December 31, 2004, was $27,777 and $4,893, respectively. The actual tax benefit realized for the tax deductions from option exercises totaled $9,210 and $1,670 for the six months ended December 30, 2005 and December 31, 2004, respectively.

 

  F. Inventories consist of the following:

 

    

December 30,

2005


   July 1,
2005


Raw materials and work-in-process

   $ 86,092    $ 82,207

Finished goods

     53,026      46,863
    

  

Total inventory

   $ 139,118    $ 129,070
    

  

 

  G. Other expense of $3,051 and $3,027 for the three and six months ended December 30, 2005, respectively, included a loss of $2,591 from the other-than-temporary decline in the fair value of an investment in a privately-held company, and losses from the decline in the cash surrender value of life insurance, partnership income, foreign exchange gains, and various other items, none of which was individually significant.

 

Other expense of $1,020 and $855 for the three and six months ended December 31, 2004, respectively, included losses on short-term investments and from the other-than-temporary decline in the fair value of an investment in a privately-held company, gains from the increase in the cash surrender value of life insurance, partnership income, foreign exchange losses, and various other items, none of which was individually significant.

 

12


  H. We have a defined benefit pension plan covering substantially all of our domestic employees. Pension expense for this plan consists of the following:

 

     Three Months Ended

    Six Months Ended

 
    

December 30,

2005


   

December 31,

2004


   

December 30,

2005


   

December 31,

2004


 

Service cost

   $ 2,188     $ 1,914     $ 4,376     $ 3,828  

Interest cost

     1,478       1,379       2,956       2,758  

Expected return on plan assets

     (1,722 )     (1,691 )     (3,444 )     (3,382 )

Amortization of transition net asset

     (12 )     (12 )     (24 )     (24 )

Amortization of prior service cost

     7       7       14       14  

Amortization of net actuarial loss

     180       46       360       92  
    


 


 


 


Pension expense

   $ 2,119     $ 1,643     $ 4,238     $ 3,286  
    


 


 


 


 

During the first quarter of fiscal year 2006, we made a contribution of $5,701 to the defined benefit pension plan. We believe no additional contributions will be made to the defined benefit pension plan in fiscal year 2006.

 

We also have unfunded defined benefit retirement plans for certain key officers and non-employee directors. Pension expense for these plans consists of the following:

 

We also have unfunded defined benefit retirement plans for certain key officers and non-employee directors. Pension expense for these plans consists of the following:

 

     Three Months Ended

   Six Months Ended

    

December 30,

2005


  

December 31,

2004


  

December 30,

2005


  

December 31,

2004


Service cost

   $ 555    $ 341    $ 1,110    $ 682

Interest cost

     864      532      1,727      1,064

Amortization of prior service cost

     22      47      45      94

Amortization of net actuarial loss

     870      428      1,739      856
    

  

  

  

Pension expense

   $ 2,311    $ 1,348    $ 4,621    $ 2,696
    

  

  

  

 

In addition to providing pension benefits, we have contributory plans that provide certain health care and life insurance benefits to retired employees. The components of postretirement benefit expense consist of the following:

 

     Three Months Ended

   Six Months Ended

    

December 30,

2005


  

December 31,

2004


  

December 30,

2005


  

December 31,

2004


Service cost

   $ 14    $ 13    $ 28    $ 26

Interest cost

     173      169      346      338

Amortization of prior service cost

     11      11      22      22

Amortization of net actuarial loss

     95      65      190      130
    

  

  

  

Postretirement expense

   $ 293    $ 258    $ 586    $ 516
    

  

  

  

 

13


  I. The following is a summary of depreciation and amortization expense:

 

     Three Months Ended

   Six Months Ended

    

December 30,

2005


  

December 31,

2004


  

December 30,

2005


  

December 31,

2004


Depreciation expense

   $ 11,134    $ 11,467    $ 22,390    $ 23,073

Amortization expense:

                           

Intangible assets

     3,084      3,729      6,238      7,578

Capitalized software

     4,529      3,298      7,913      5,593

Premiums on short-term investments

     1,912      1,931      3,606      4,206
    

  

  

  

Total

   $ 20,659    $ 20,425    $ 40,147    $ 40,450
    

  

  

  

 

  J. We offer warranties of various lengths to our customers depending on the specific product and the terms of the agreements with the customer. Our standard warranties require us to repair or replace defective product returned to us during the warranty period at no cost to the customer. We record an estimate for warranty-related costs based on our actual historical and/or projected failure rates and repair costs at the time of sale. We repair products in our manufacturing facilities and also outsource warranty repairs. Historical and/or projected failure rates and repair costs are reviewed and the estimated warranty liability is adjusted, if required, quarterly. In addition, for certain purchased products, such as cable modems and hard drives included in our set-tops, we generally provide the same warranty coverage to our customers as the supplier of the products provides to us. Expenses related to unusual product warranty problems and product defects are recorded in the period the problem is identified.

 

We offer extended warranties on certain products. Revenue from these extended warranty agreements is deferred at the time of the sale and recognized in future periods according to the terms of the warranty agreement. The warranty liability at December 30, 2005 consisted of $13,738 in Accrued liabilities and $27,239 in Other liabilities in the Consolidated Statements of Financial Position.

 

The following reconciles the beginning warranty liability at July 1, 2005 to the warranty liability at December 30, 2005:

 

Accrued warranty at July 1, 2005

   $ 45,024  

Reductions for payments

     (12,382 )

Additions for warranties issued during the period

     10,264  

Other adjustments

     (1,929 )
    


Accrued warranty at December 30, 2005

   $ 40,977  
    


 

  K. U.S. income taxes, net of applicable credits, have been provided on the undistributed earnings of foreign subsidiaries, except in those instances where the earnings are expected to be indefinitely reinvested. Scientific-Atlanta currently intends to indefinitely reinvest approximately $91,000 of undistributed earnings of foreign subsidiaries; however, this amount may be adjusted based on changes in business, economic or other conditions.

 

At December 30, 2005, approximately $70,000 of such undistributed earnings had been indefinitely reinvested.

 

  L. We perform annual goodwill impairment tests to identify potential impairment by comparing the fair value of the reporting unit with its net book value, including goodwill. We test for impairment at the operating segment level (subscriber and transmission). Estimates of fair value are determined using discounted cash flows and market comparisons. We perform internal valuation analyses and consider other market information that is publicly available. These analyses use significant estimates and assumptions, including projected future cash flows (including timing), discount rates reflecting the risk inherent in future cash flows, determination of appropriate comparables and the determination of whether a premium or discount should be applied to comparables. These estimates and assumptions are reviewed and updated annually based on actual results and future projections. Changes in these estimates and assumptions may result in a determination that goodwill is impaired and could have a significant impact on our operating results.

 

14


In addition to our annual impairment test, Scientific-Atlanta continually evaluates whether events and circumstances have occurred that indicate that the remaining balance of goodwill may not be recoverable. The results of our assessments did not result in any determination of an impairment of goodwill during the first six months of fiscal year 2006.

 

  M. We operate in one reportable segment, the broadband segment, which consists of our subscriber and transmission operating segments. We have combined these operating segments into a single reportable segment under the aggregation criteria of SFAS No. 131, “Disclosures about Segments of an Enterprise and Related Information.” Operating segments may be aggregated into a single operating segment if the segments have similar economic characteristics, and if the segments are similar in: 1) the nature of products and services; 2) the nature of production processes; 3) the type or class of customer for their products and services; 4) the methods used to distribute their products or provide their services; and 5) the nature of the regulatory environment. We believe our subscriber and transmission operating segments meet all of these criteria and that aggregation is consistent with the objective and basic principles of SFAS No. 131.

 

  N. The following disclosure related to contingencies was included in the Notes to the Consolidated Financial Statements included in our Annual Report on Form 10-K for the fiscal year ended July 1, 2005 and continues to be relevant.

 

Adelphia Communications Corporation (Adelphia), a customer of Scientific-Atlanta, filed for bankruptcy protection under Chapter 11 of the U.S. Bankruptcy Code in June 2002. In the third quarter of fiscal year 2002, during the 90 days prior to such filing by Adelphia, we received payments from Adelphia for goods sold and delivered of approximately $67,000, and we are unable to predict the portion, if any, of this amount which might be the subject of avoidance claims by the Chapter 11 estate of Adelphia in connection with its bankruptcy proceeding. We have entered into a tolling agreement for any potential claims by the Adelphia estate where the statute of limitation has not yet run.

 

During fiscal year 2002, we wrote off accounts receivable of $89,652 from Adelphia resulting from its filing for bankruptcy in fiscal year 2002. We are unable to predict the portion, if any, of this amount we might recover.

 

  O. In November 2004, the Financial Accounting Standards Board (FASB) issued SFAS No. 151, “Inventory Costs, an Amendment of ARB No. 43, Chapter 4.” SFAS No. 151 requires that abnormal amounts of idle facility expense, freight, handling costs, and spoilage, be charged to expense in the period they are incurred rather than capitalized as a component of inventory costs. SFAS No. 151 is effective for inventory costs incurred in fiscal periods beginning after June 15, 2005. The adoption of this Statement in the first quarter of fiscal year 2006 did not have a material impact on our results of operations. The application of this standard may result in higher expenses in periods where production levels are lower than normal ranges of production. Because actual future production levels are subject to many factors, including demand for our products, we cannot determine if the adoption of SFAS No. 151 will have a material impact on future results of operations.

 

In December 2004, the FASB issued SFAS No. 123R, which requires all companies to measure compensation cost for all share-based payments, including employee stock options, at fair value effective for public companies for annual periods beginning after June 15, 2005. Scientific-Atlanta adopted SFAS No. 123R in the first quarter of fiscal year 2006, as discussed further in Note C. SFAS No. 123R also requires the benefits of tax deductions in excess of recognized compensation cost be reported as a financing cash flow, rather than as an operating cash flow as required under prior guidance. This requirement reduced net operating cash flows and increased net financing cash flows for the six months ended December 30, 2005 in the amount of $4,163.

 

The FASB also issued FASB Staff Position (FSP) No. 109-1, “Application of FASB Statement No. 109, Accounting for Income Taxes, to the Tax Deduction on Qualified Production Activities Provided by the American Jobs Creation Act of 2004 (the Act),” and FSP No. 109-2, “Accounting and Disclosure Guidance for the Foreign Earnings Repatriation Provision within the American Jobs Creation Act of 2004”. Under the guidance in FSP No. 109-1, the deduction will be treated as a “special deduction” as described in SFAS No. 109. As such, the special deduction has no effect on deferred tax assets and liabilities existing at the enactment date. Rather, the impact of this deduction will be reported in the period in which the deduction is claimed on our income tax return. FSP No. 109-2 allows enterprises time beyond the financial reporting period of the enactment of the Act to evaluate the effects of the Act on its plan for reinvestment or repatriation of foreign earnings for purposes of applying SFAS No. 109 due to the lack of clarification of certain provisions within the Act and the timing of the enactment. As such, we are not yet in a position to decide on whether, and to what extent, we might repatriate foreign earnings that have not yet been remitted to the U.S. Based on our analysis to date, however, it is reasonably possible that we may repatriate some amount ranging from $0 to $80,000, with the respective tax cost ranging from $0 to $1,000. We expect to be in a position to finalize our assessment by March 31, 2006.

 

15


In May 2005, the FASB issued SFAS No. 154, “Accounting Changes and Error Corrections,” which requires retrospective application to prior periods’ financial statements of changes in accounting principle. This Statement also requires that a change in depreciation or amortization method for long-lived, non-financial assets be accounted for as a change in accounting estimate effected by a change in accounting principle. In addition, this Statement requires that any error, other than an immaterial error, in the financial statements of a prior period be reported as a prior period adjustment by restating the prior period financial statements. SFAS No. 154 will be effective for accounting changes and corrections of errors made in fiscal years beginning after December 15, 2005. At this time, we cannot determine if the adoption of this Statement will have a material impact on future results of operations.

 

16


MANAGEMENT’S DISCUSSION AND ANALYSIS

OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

OVERVIEW

 

Sales for three months ended December 30, 2005 were $495.2 million, an increase of 12 percent over the comparable period of the prior year. Sales of subscriber products were $372.8 million, up 14 percent over the prior year. The year-over-year increase in sales of subscriber products was due to higher volumes of Explorer® digital set-tops and WebSTAR cable modems and a continued mix shift toward higher-end set-top and modem products. Gross margins of 36.1 percent were one percentage point lower than in the prior year. Operating expenses increased $19.1 million over the prior year due primarily to expenses related to the pending acquisition by Cisco and stock compensation expense. Net earnings for the three months of $53.4 million were $5.2 million lower than last year. Earnings generated by the higher sales volume in the three months ended December 30, 2005 as compared to the prior year were more than offset by lower gross margins and higher operating expenses.

 

In November 2005, we announced an agreement to be acquired by Cisco. On February 2, 2006, the shareholders of the company approved the acquisition at a special meeting of the shareholders. The companies expect the transaction to be consummated in the first calendar quarter of 2006.

 

FINANCIAL CONDITION AND LIQUIDITY

 

Scientific-Atlanta had stockholders’ equity of $2.2 billion and cash and cash equivalents of $584.8 million at December 30, 2005. We also had $1.1 billion of short-term investments at December 30, 2005. Cash provided by operating activities for the six months ended December 30, 2005 of $121.4 million included net earnings of $114.2 million. Accounts receivable and inventory increased $26.2 million and $8.4 million, respectively. In addition, accounts payable and accrued liabilities decreased by of $15.2 million and $6.7 million, respectively. The increase in accounts receivable relates to the timing of shipments. The increase in inventory relates to increased demand for cable modems for which shipments were disrupted due to a technical issue that was resolved late in the second quarter, production of new products we expect to begin shipping in the second half of fiscal year 2006, product mix, and reduced forecast visibility. Accrued liabilities decreased primarily due to the payment of fiscal year 2005 incentives on performance based incentive plans.

 

During the six months ended December 30, 2005, we increased our short-term investments by $17.8 million and acquired property, plant and equipment of $16.7 million. In addition, we acquired the outstanding interest in Scientific-Atlanta Shanghai Limited joint venture from its shareholders for a cash payment of $4.3 million.

 

The current ratio of Scientific-Atlanta was 6.2:1 at December 30, 2005, up from 5.4:1 at July 1, 2005. At December 30, 2005, we had debt of $6.8 million, primarily on mortgages on facilities we assumed in connection with the acquisition of BarcoNet NV during fiscal year 2002. We believe that funds generated from operations, existing cash and short-term investment balances and our available senior credit facility will be sufficient to support operations.

 

RESULTS OF OPERATIONS

 

Sales for the quarter ended December 30, 2005 were $495.2 million, up 12 percent or $53.6 million over the prior year. International sales for the second quarter of fiscal year 2006 were $145.0 million, up 25 percent over the prior year. Year-over-year, international sales were up in all regions.

 

Sales of subscriber products for the quarter ended December 30, 2005 increased 14 percent from the prior year’s second quarter to $372.8 million. In the second quarter of fiscal year 2006, we sold 1.2 million Explorer digital set-tops as compared to 911 thousand in the prior year. During the second quarter of fiscal year 2006, we also sold 981 thousand WebSTAR cable modems, up from 460 thousand in the prior year. Sales of transmission products during the second quarter of fiscal year 2006 totaled $122.4 million, an increase of 7 percent from the prior year.

 

During the quarter ended December 30, 2005, we sold 556 thousand set-tops with digital video recording capability (DVRs), including 295 thousand units of our standard-definition model and 261 thousand units of our high-definition DVR model. We also sold 125 thousand high-definition set-tops without DVR capability. Together with the high-definition DVRs mentioned previously, we sold 386 thousand high-definition set-tops in the quarter, an increase of more than 27 percent compared to the same quarter last year.

 

Sales for the six months ended December 30, 2005 were $985.3 million, up 10 percent from $894.3 million in the first six months of the prior year. Sales of subscriber products were $733.6 million, an increase of 11 percent from the prior year. We sold approximately 2.3 million digital set-tops during the six months ended December 30, 2005, an increase from 1.9

 

17


million units sold the first 6 months of last year. Of the approximately 2.3 million digital set-tops sold, more than 1.0 million of the digital set-tops included digital video recording capability. This is an increase from approximately 846 thousand shipped during the six months of last year. Sales of transmission products were $251.8 million, an increase of 8 percent compared to the first six months of last year. International sales for the first six months of fiscal year 2006 totaled $279.5 million, up 31 percent compared to the first six months last year. Sales in all international regions increased compared to the first six months of last year.

 

Gross margin in the second quarter of fiscal year 2006 was 36.1 percent of sales, a decline of 1.0 percentage points from the second quarter of last year. The decline was related primarily to less favorable product mix, expenses related to a cable modem product issue that was resolved during the second quarter, and the expensing of stock options. In addition, lower selling prices in the quarter ended December 30, 2005 as compared to last year continue to pressure gross margin. The impact of the lower sales prices on gross margin continues to be mitigated by a reduction in material and conversion costs compared to last year. The overall average selling price of our digital set-tops decreased approximately 12 percent in the second quarter of fiscal year 2006 compared to the second quarter of fiscal year 2005. The decrease in the combined average selling price of digital set-tops is attributable to the decline in average prices across all individual set-top models compared to the second quarter of last year. Although the price of individual models of digital set-tops may decline in the future, the average selling price of digital set-tops will vary based on the mix of models sold during the period. We continue to focus on cost reductions through product design, procurement and manufacturing.

 

Gross margin was 36.8 percent of sales for the six months of fiscal year 2006, flat with the first six months of the prior year. Lower selling prices of digital set-tops across most set-top models combined with unfavorable product mix pressured gross margin, but the impacts were offset by a reduction in material and conversion costs together with the leverage of a 10 percent increase in sales compared to the first six months of last year.

 

Research and development expenses for the three and six months ended December 30, 2005 were $40.4 million and $84.6 million, respectively, up seven percent and 11 percent, respectively, over the comparable periods of the prior year. The primary driver of the year-over-year increases was the incremental hiring related to new set-top and advanced encoder designs. In addition, research and development expenses included stock compensation expense of $1.7 million and $3.5 million for the three and six months ended December 30, 2005, respectively. No such expense was recorded in fiscal year 2005. These increases were offset partially by higher capitalization of software development costs in the three and six months ended December 30, 2005 as compared to the comparable periods of the prior year.

 

Sales and administrative expenses for the three months ended December 30, 2005 were $64.2 million, up $16.3 million over the comparable period of the prior year. Sales and administrative expenses for the three months ended December 30, 2005 included $6.7 million of stock compensation expense and $6.6 million of expenses related to the pending acquisition by Cisco. Sales and administrative expenses of $121.3 million for the six months ended December 30, 2005 included $13.2 million of stock compensation expense. No such expense was recorded in fiscal year 2005.

 

Restructuring charges of $0.3 million and $1.2 million for the three and six months ended December 30, 2005, respectively, are primarily for severance and relate to the consolidation of certain facilities in Europe. We do not anticipate recording significant restructuring charges during fiscal year 2006.

 

Interest income of $12.5 million and $23.2 million for the three and six months ended December 30, 2005, respectively, was up significantly over the comparable periods of the prior year due to both higher average cash and short-term investment balances and higher tax-equivalent yields in fiscal year 2006 as compared to fiscal year 2005. The average tax-equivalent yield was 3.7 percent and 3.5 percent for the three and six months ended December 30, 2005, respectively, compared to 2.3 percent and 2.1 percent for the three and six months ended December 31, 2004, respectively.

 

Other expense of $3.1 million and $3.0 million for the three and six months ended December 30, 2005, respectively, included a loss of $2.6 million from the other-than-temporary decline in the fair value of an investment in a privately-held company, and losses from the decline in the cash surrender value of life insurance, partnership income, foreign exchange gains, and various other items, none of which was individually significant.

 

Other expense of $1.0 million and $0.9 million for the three and six months ended December 31, 2004, respectively, included losses on short-term investments and from the other-than-temporary decline in the fair value of an investment in a privately-held company, gains from the increase in the cash surrender value of life insurance, partnership income, foreign exchange losses, and various other items, none of which was individually significant.

 

Earnings before income taxes of $83.5 million for the three months ended December 30, 2005 were flat compared to the prior year. Higher sales volume and interest income in fiscal year 2006 were offset by lower gross margin, stock

 

18


compensation expense and expenses related to the pending acquisition by Cisco. Earnings before income taxes of $175.3 million for the six months ended December 30, 2005 were up $7.3 million over the prior year. Higher sales volume, increased capitalization of software development costs and higher interest income in fiscal year 2006 were offset partially by stock compensation expense and expenses related to the pending acquisition by Cisco.

 

The effective tax rate for the three months ended December 31, 2005 was 36 percent of pre-tax earnings, up from 30 percent in the prior year, due primarily to various discrete items in the quarter, the most significant of which was non-deductible costs associated with the pending acquisition by Cisco.

 

The effective tax rate for the six months ended December 31, 2005 was 35 percent of pre-tax earnings, up from 32 percent in the prior year, due primarily to the item discussed above. We believe that our effective tax rate will be approximately 34 percent of pre-tax earnings for fiscal year 2006.

 

On October 22, 2004, the President of the United States signed the American Jobs Creation Act of 2004. The Act creates a temporary incentive for U.S. corporations to repatriate accumulated income earned abroad by providing an 85 percent dividend received deduction for certain dividends from controlled foreign corporations. The deduction is subject to a number of limitations and, as of today, uncertainty remains as to how to interpret numerous provisions in the Act. As such, we are not yet in a position to decide on whether, and to what extent, we might repatriate foreign earnings that have not yet been remitted to the U.S. Based on our analysis to date, however, it is reasonably possible that we may repatriate some amount ranging from $0 to $80 million, with the respective tax cost ranging from $0 to $1 million. We expect to be in a position to finalize our assessment by March 31, 2006.

 

The Act also creates a deduction for income from qualified domestic production activities which will be phased in from 2005 through 2010, effective for our fiscal years 2006 through 2011. In return, the Act also provides for a two-year phase-out of the existing extra-territorial income exclusion (ETI) for foreign sales that was viewed to be inconsistent with international trade protocols by the European Union. We expect the phase out of ETI to result in an immaterial increase in the effective tax rate for fiscal years 2006 and 2007. The new deduction for domestic production activities is subject to certain limitations and interpretations and, as such, we are not yet in a position to determine the potential impact on the effective tax rate for fiscal year 2006.

 

Under the guidance in FSP No. 109-1, “Application of FASB Statement No. 109, Accounting for Income Taxes, to the Tax Deduction on Qualified Production Activities Provided by the American Jobs Creation Act of 2004,” the deduction will be treated as a “special deduction” as described in SFAS No. 109. As such, the special deduction has no effect on deferred tax assets and liabilities existing at the enactment date. Rather, the impact of this deduction will be reported in the period in which the deduction is claimed on our income tax return.

 

Effective July 2, 2005, we adopted SFAS No. 123R’s, “Share-Based Payment,” fair value method using its modified prospective transition method. Under this transition method, compensation cost recognized after adoption includes: a) compensation cost for all share-based payments granted prior to, but not yet vested as of July 2, 2005, based on the grant date fair value estimated in accordance with the original provisions of SFAS No. 123, “Accounting for Stock-Based Compensation,” and b) compensation cost for all share-based payments granted subsequent to July 2, 2005, based on the grant-date fair value estimated in accordance with the provisions of SFAS No. 123R. Prior to July 2, 2005 as permitted by SFAS No. 123, we accounted for share-based payments to employees using Accounting Principles Board (APB) Opinion No. 25’s, “Accounting for Stock Issued to Employees”, intrinsic value method and, as such, recognized no compensation cost for employee stock options. Results for prior periods have not been restated.

 

As a result of adopting SFAS No. 123R on July 2, 2005, the company’s income before income taxes and net income for the six months ended December 30, 2005, were $19.5 million and $12.7 million lower, respectively, than if it had continued to account for share-based compensation under APB Opinion No. 25. Stock option compensation expense of $2.8 million, $3.5 million and $13.2 million was included in cost of sales, research and development, and sales and administrative expense, respectively. Basic and diluted earnings per share for the six months ended December 30, 2005 would have been $0.83 and $0.82, respectively, if the company had not adopted SFAS No. 123R, compared to reported basic and diluted earnings per share of $0.74 and $0.74, respectively.

 

Critical Accounting Policies

 

Note 1 to the Consolidated Financial Statements in Form 10-K for fiscal year 2005 includes a summary of the significant accounting policies or methods used in the preparation of our consolidated financial statements. Some of those significant accounting policies or methods require us to make estimates and assumptions that affect the amounts reported by us. We believe the following items require the most significant judgments and often involve complex estimates.

 

19


General

 

The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. We base our estimates and judgments on historical experience and various other factors we believe to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions. Historically, actual results have not differed materially from our estimates. The most significant estimates and assumptions relate to revenue recognition, stock compensation, the adequacy of receivable, inventory and tax reserves, deferred tax allowances, asset impairments and accrued liabilities and other liabilities, principally relating to warranty provisions, the pension benefit liability and settlement liabilities.

 

Revenue Recognition

 

Our principal sources of revenues are from sales of interactive subscriber systems which include digital set-tops and cable modems, broadband transmission networks and content distribution networks. We recognize revenue when (1) there is persuasive evidence of an agreement with the customer, (2) product is shipped and title has passed, (3) the amount due from the customer is fixed and determinable, (4) collectibility is reasonably assured, and (5) we have no significant future performance obligation. At the time of the transaction, we assess whether the amount due from the customer is fixed and determinable and collection of the resulting receivable is reasonably assured. We assess whether the amount due from the customer is fixed and determinable based on the terms of the agreement with the customer, including, but not limited to, the payment terms associated with the transaction. We assess collection based on a number of factors, including past transaction history with the customer and credit-worthiness of the customer. If we determine that collection of an amount due is not reasonably assured, we defer recognition of revenue until collection becomes reasonably assured.

 

The standard terms and conditions under which we ship allow a customer the right to return product for refund only if the product does not conform to product specifications, the non-conforming product is identified by the customer, and the customer rejects the non-conforming product and notifies us within ten days of receipt. If an agreement contains a non-standard right of return, we defer recognizing revenue until the conditions of the agreement are met. From time to time, our agreements include acceptance clauses. If an agreement includes an acceptance clause, revenue is deferred until acceptance is deemed to have occurred.

 

Agreements with multiple deliverables are reviewed and the deliverables are separated into units of accounting under the provisions of Emerging Issues Task Force (EITF) No. 00-21. We recognize revenue from these agreements based on the relative fair value of the products and services. The determination of the fair value of the elements, which is based on a variety of factors, including the amount we charge other customers for the products or services, price lists or other relevant information, requires judgment by management. If an undelivered element is essential to the functionality of the delivered element or required under the terms of the contract to be delivered concurrently, we defer the revenue on the delivered element until that undelivered element is delivered. In some cases, the total consideration received is allocated over the relative fair value of the units of accounting. Revenue is recognized as the elements are delivered, assuming all the other conditions for recognition of revenue discussed in the preceding paragraphs have been met.

 

For certain products where software is more than an incidental component of the hardware, we recognize software license revenue under Statement of Position (SOP) No. 97-2, “Software Revenue Recognition,” as amended by SOP No. 98-9, “Software Revenue Recognition, with Respect to Certain Transactions.” Software revenue recognition rules are very complex. Although we follow very specific and detailed guidelines in measuring revenue, the application of those guidelines requires judgment, including whether the software is more than an incidental component of the hardware and whether a software arrangement includes multiple elements, and if so, whether vendor-specific objective evidence of fair value exists for any undelivered elements.

 

Stock-Based Compensation

 

Effective July 2, 2005, we adopted SFAS No. 123R’s fair value method using its modified prospective transition method. Under this transition method, compensation cost recognized after adoption includes: a) compensation cost for all share-based payments granted prior to, but not yet vested as of July 2, 2005, based on the grant date fair value estimated in accordance with the original provisions of SFAS No. 123, and b) compensation cost for all share-based payments granted subsequent to July 2, 2005, based on the grant-date fair value estimated in accordance with the provisions of SFAS No. 123R. Results for prior periods have not been restated. SFAS No. 123R also requires the benefits of tax deductions in excess of recognized compensation cost be reported as a financing cash flow, rather than as an operating cash flow as required under prior guidance. This requirement reduced net operating cash flows in the amount of $4.2 million for the six months ended December 30, 2005.

 

20


As a result of adopting SFAS No. 123R on July 2, 2005, the company’s income before income taxes and net income for the six months ended December 30, 2005, were $19.5 million and $12.7 million lower, respectively, than if the company had continued to account for share-based compensation under APB Opinion No. 25. Basic and diluted earnings per share for the six months ended December 30, 2005 would have been $0.83 and $0.82, respectively, if the company had not adopted SFAS No. 123R, compared to reported basic and diluted earnings per share of $0.74 and $0.74, respectively.

 

Management judgments and assumptions related to volatility, the expected term and the forfeiture rate are made in connection with the calculation of stock compensation expense. We periodically review all assumptions used in our stock option pricing model. Changes in these assumptions could have a significant impact on the amount of stock compensation expense.

 

Inventory Reserves

 

We regularly review inventory quantities on hand and record a provision for excess and obsolete inventory based primarily on our estimated forecast of product demand and production requirements for the next twelve months. In addition, our industry is characterized by rapid technological change, frequent introductions of new products and rapid product obsolescence that could result in an increase in the amount of obsolete inventory on hand. Recently, the rate at which we introduce new products has accelerated, which also may result in an increase in the amount of obsolete inventory on hand. Any significant, unanticipated changes in demand or technological developments could have a significant impact on the value of our inventory and operating results.

 

Income Taxes

 

We recognize deferred tax assets and liabilities based on the differences between the financial statement carrying amounts and the tax basis of assets and liabilities. We regularly review our deferred tax assets for recoverability and establish a valuation allowance based on historical taxable income, projected future taxable income, the expected timing of the reversals of existing temporary differences and the implementation of tax planning strategies. If we are unable to generate sufficient future taxable income in certain tax jurisdictions, or if there is a material change in the actual effective tax rates or time period within which the underlying temporary differences become taxable or deductible, we could be required to increase the valuation allowance against our deferred tax assets, resulting in an increase in the effective tax rate and an adverse impact on operating results.

 

Management judgments and estimates are made in connection with establishing and adjusting valuation allowances on deferred tax assets, estimated tax payments and tax reserves. Changes in these estimates could have a significant impact on our operating results.

 

Goodwill Impairment

 

We perform annual goodwill impairment tests to identify potential impairment by comparing the fair value of the reporting unit with its net book value, including goodwill. We test for impairment at the operating segment level (subscriber and transmission). Estimates of fair value are determined using discounted cash flows and market comparisons. We perform internal valuation analyses and consider other market information that is publicly available. These analyses use significant estimates and assumptions, including projected future cash flows (including timing), discount rates reflecting the risk inherent in future cash flows, determination of appropriate comparables and the determination of whether a premium or discount should be applied to comparables. These estimates and assumptions are reviewed and updated annually based on actual results and future projections. Changes in these estimates and assumptions may result in a determination that goodwill is impaired and could have a significant impact on our operating results.

 

Segments

 

We operate in one reportable segment, the Broadband segment, which consists of our subscriber and transmission operating segments. We have combined these operating segments into a single reportable segment under the aggregation criteria of SFAS No. 131, “Disclosures about Segments of an Enterprise and Related Information.” Operating segments may be aggregated into a single operating segment if the segments have similar economic characteristics, and if the segments are similar in 1) the nature of products and services; 2) the nature of production processes; 3) the type or class of customer for their products and services; 4) the methods used to distribute their products or provide their services; and 5) the nature of the regulatory environment. We believe our subscriber and transmission operating segments meet all of these criteria and that aggregation is consistent with the objective and basic principles of SFAS No. 131.

 

21


Warranty Costs

 

We offer warranties of various lengths to our customers depending on the specific product and the terms of the agreements with the customer. Our standard warranties require us to repair or replace defective product returned to us during the warranty period at no cost to the customer. We record an estimate for warranty-related costs based on our historical and/or projected failure rates and repair costs at the time of sale. We repair products in our manufacturing facilities and also outsource warranty repairs. Historical and/or projected failure rates and repair costs are reviewed and the estimated warranty liability is adjusted, if required, quarterly. Expenses related to an unusual product warranty problem and product defect are recorded in the period the problem is identified. A significant increase in product failure rates, in the costs to repair our products or in the amount of warranty repairs outsourced could have a significant impact on our operating results. For certain purchased products, such as cable modems and hard drives, included in our set-tops, we generally provide the same warranty coverage to our customers as the supplier of the products provides to us. Failure of the supplier to honor its warranty commitment to us could also have a significant impact on our operating results. The warranty liability was $41.0 million and $45.0 million at December 30, 2005 and July 1, 2005, respectively. A rollforward of the warranty liability from July 1, 2005 to December 30, 2005 is included in Note J to the Consolidated Financial Statements in this Form 10-Q.

 

Pension Assumptions

 

The pension benefit liability and the related effects on our operating results are calculated using actuarial models. We use March 31 as a measurement date for all actuarial calculations of asset and liability values and significant actuarial assumptions. Two critical assumptions, discount rate and expected return on assets, are important elements of plan expense and/or liability measurement. We re-evaluate these assumptions annually. Other assumptions involve demographic factors such as retirement, mortality, rate of compensation increase and turnover. These assumptions are also re-evaluated annually and are updated to reflect our experience. The discount rate is required to represent the market rate for high-quality fixed income investments. In selecting the discount rate, we also consider the timing of expected future cash flows. To determine the expected long-term rate of return on pension plan assets, we consider the historical and expected returns on the plan assets, as well as the current and expected allocation of the plan assets.

 

At March 31, 2004, we reduced the discount rate used to calculate the pension benefit liability and expense from 6.50 percent to 6.00 percent to reflect the lower market interest conditions. This change in our assumptions increased our pension expense by approximately $0.3 million in fiscal year 2005 over the preceding year. At March 31, 2005, we reduced the discount rate to 5.75 percent to reflect the lower market interest conditions. This change in our assumptions will increase our pension expense by $0.2 million in fiscal year 2006 over fiscal year 2005. The expected long-term rate of return on pension assets was 8.00 percent in fiscal years 2005, 2004 and 2003.

 

Actual results in any given year will often differ from actuarial assumptions because of economic and other factors. The difference between actual results and actuarial assumptions could have a significant impact on our operating results.

 

Allowance for Doubtful Accounts

 

Management judgments and estimates are made in connection with establishing the allowance for doubtful accounts. Specifically, we analyze the aging of accounts receivable balances, historical bad debts, customer concentrations, customer credit-worthiness, current economic trends and changes in our customer payment terms. Significant changes in customer concentration or payment terms, deterioration of customer credit-worthiness, as in the case of the bankruptcy of Adelphia, or weakening in economic trends could have a significant impact on the collectibility of receivables and our operating results. Generally, we do not require collateral or other security to support accounts receivable.

 

New Accounting Pronouncements

 

In November 2004, the FASB issued SFAS No. 151, “Inventory Costs, an Amendment of ARB No. 43, Chapter 4.” SFAS No. 151 requires that abnormal amounts of idle facility expense, freight, handling costs, and spoilage, be charged to expense in the period they are incurred rather than capitalized as a component of inventory costs. SFAS No. 151 is effective for inventory costs incurred in fiscal periods beginning after June 15, 2005. The adoption of this Statement in the first quarter of fiscal year 2006 did not have a material impact on our results of operations. The application of this standard may result in higher expenses in periods where production levels are lower than normal ranges of production. Because actual future production levels are subject to many factors, including demand for our products, we cannot determine if the adoption of SFAS No. 151 will have a material impact on future results of operations.

 

The FASB also recently issued FSP No. 109-1, “Application of FASB Statement No. 109, Accounting for Income Taxes, to the Tax Deduction on Qualified Production Activities Provided by the American Jobs Creation Act of 2004,” and FSP No. 109-2, “Accounting and Disclosure Guidance for the Foreign Earnings Repatriation Provision within the American

 

22


Jobs Creation Act of 2004”. Under the guidance in FSP No. 109-1, the deduction will be treated as a “special deduction” as described in SFAS No. 109. As such, the special deduction has no effect on deferred tax assets and liabilities existing at the enactment date. Rather, the impact of this deduction will be reported in the period in which the deduction is claimed on our income tax return. FSP No. 109-2 allows enterprises time beyond the financial reporting period of the enactment of the Act to evaluate the effects of the Act on its plan for reinvestment or repatriation of foreign earnings for purposes of applying SFAS No. 109 due to the lack of clarification of certain provisions within the Act and the timing of the enactment. As such, we are not yet in a position to decide on whether, and to what extent, we might repatriate foreign earnings that have not yet been remitted to the U.S. Based on our analysis to date, however, it is reasonably possible that we may repatriate some amount ranging from $0 to $80 million, with the respective tax cost ranging from $0 to $1 million. We expect to be in a position to finalize our assessment by March 31, 2006.

 

In May 2005, the FASB issued SFAS No. 154, “Accounting Changes and Error Corrections,” which requires retrospective application to prior periods’ financial statements of changes in accounting principle. This Statement also requires that a change in depreciation or amortization method for long-lived, non-financial assets be accounted for as a change in accounting estimate effected by a change in accounting principle. In addition, this Statement requires that any error, other than an immaterial error, in the financial statements of a prior period be reported as a prior period adjustment by restating the prior period financial statements. SFAS No. 154 will be effective for accounting changes and corrections of errors made in fiscal years beginning after December 15, 2005. At this time, we cannot determine if the adoption of this Statement will have a material impact on future results of operations.

 

Off-Balance Sheet Financing Arrangements

 

Scientific-Atlanta has no off-balance sheet financing arrangements.

 

* * * * * * * * * * * * * * * * * * * * * * * * * * * *

 

Any statements in Management’s Discussion and Analysis of Financial Condition and Results of Operations that are not statements about historical facts are forward-looking statements. Such forward-looking statements are based upon current expectations but involve risks and uncertainties. Investors are referred to the Cautionary Statements and Risk Factors contained in Exhibit 99.1 to this Form 10-Q for a description of the various risks and uncertainties that could cause Scientific-Atlanta’s actual results and experience to differ materially from the anticipated results or other expectations expressed in Scientific-Atlanta’s forward- looking statements. Such Exhibit 99.1 is hereby incorporated by reference into Management’s Discussion and Analysis of Financial Condition and Results of Operations.

 

Scientific-Atlanta, the Scientific-Atlanta logo, Explorer and PowerVu, are registered trademarks of Scientific-Atlanta, Inc. WebSTAR, 8000 and MCP-100 are trademarks of Scientific-Atlanta, Inc.

 

 

23


ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISKS

(Amounts in thousands)

 

We are exposed to market risks from changes in foreign exchange rates and have a process to monitor and manage these risks. Scientific-Atlanta enters into foreign exchange forward contracts to hedge certain forecasted transactions, firm commitments, and assets denominated in currencies other than the U.S. dollar. These contracts are primarily used to hedge transactions with certain subsidiaries whose transactional currency is other than the U.S. dollar; whose inflow of local currency is insufficient to meet operating expenses denominated in local currency; or trade receivables denominated in a currency other than the subsidiary’s functional currency. The contracts, which qualify as cash flow or fair value hedges, are designated as hedging instruments at inception, are for periods consistent with the exposure being hedged and generally have maturities of one year or less. Contracts are recorded at fair value. Changes in the fair value of derivatives are recorded in other comprehensive income until the underlying transaction affects earnings for cash flow hedges and other (income) expense, net for fair value hedges.

 

The effectiveness of the hedge is based on a high correlation between the changes in its value and the value of the underlying hedged item. Any ineffectiveness is recorded through earnings. We recorded charges of $36 and $22 for ineffectiveness in the first six months of fiscal years 2006 and 2005, respectively.

 

Our foreign exchange forward contracts do not significantly subject our results of operations to risk due to exchange rate fluctuations because gains and losses on these contracts generally offset losses and gains on the exposure being hedged.

 

Foreign exchange forward contracts at December 30, 2005 were as follows:

 

     Cash Flow Hedges

   Fair Value Hedges

 
    

Canadian

Dollars


  

Mexican

Pesos


  

Canadian

Dollars


    Euros

   

Australian

Dollars


 

Notional amount of foreign exchange forward buy (sales) contracts

   8,500    31,000    (2,800 )   (12,291 )   (1,580 )

Average contract amount (Foreign currency/United States dollar)

   1.19    10.76    1.23     0.84     1.37  

 

At December 30, 2005, we had an unrealized gain of $33, net of tax of $22, related to cash flow hedges, which was included in Accumulated other comprehensive income. Scientific-Atlanta has no derivative exposure beyond the first quarter of fiscal year 2007.

 

Unrealized gains and losses on foreign exchange forward contracts which are accounted for as fair value hedges or which do not meet the criteria for hedge accounting are recognized in Other income. During the six months ended December 30, 2005 and December 31, 2004, we recorded losses of $595 and $667, respectively, related to these contracts.

 

We also have market risks associated with the volatility of our investments in privately-held companies, which consist primarily of securities of emerging technology companies. These investments are carried at cost and are evaluated periodically to determine if declines in fair value are other-than-temporary. Declines in value judged to be other-than-temporary are included in Other income. We recorded losses of $2,591 and $692 in the first six months of fiscal years 2006 and 2005, respectively. Investments in privately-held companies of $288 and $3,129 were included in Other assets in the Consolidated Statements of Financial Position at December 30, 2005 and July 1, 2005, respectively.

 

ITEM 4. CONTROLS AND PROCEDURES

 

(a) Disclosure Controls and Procedures. Scientific-Atlanta’s management, with the participation of its Chief Executive Officer and Chief Financial Officer, has evaluated the effectiveness of Scientific-Atlanta’s disclosure controls and procedures (as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (Exchange Act), as of the end of the period covered by this report. Based on such evaluation, Scientific-Atlanta’s Chief Executive Officer and Chief Financial Officer have concluded that, as of the end of such period, the company’s disclosure controls and procedures are effective in recording, processing, summarizing and reporting, on a timely basis, information required to be disclosed by Scientific-Atlanta in the reports that it files or submits under the Exchange Act.

 

(b) Internal Control Over Financial Reporting. There have not been any changes in Scientific-Atlanta’s internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during the second quarter of fiscal year 2006 that have materially affected, or are reasonably likely to materially affect, Scientific-Atlanta’s internal control over financial reporting.

 

 

24


PART II – OTHER INFORMATION

 

Item 1. Legal Proceedings.

 

Legal Proceedings Regarding the Merger

 

As previously reported in our Definitive Proxy Statement filed on January 3, 2006, we were named a defendant in a purported shareholder class action complaint, captioned Fadem v. Scientific-Atlanta, Inc. et al., filed in the Superior Court of Fulton County of the State of Georgia on November 22, 2005. On November 23, 2005, we were named a defendant in a second purported shareholder class action complaint, captioned Barone v. Scientific-Atlanta, Inc. et al., also filed in the Superior Court of Fulton County of the State of Georgia. The two actions have been consolidated under the case style In re Scientific-Atlanta, Inc. Shareholder Litigation, Case No. 2005-CV-109014, and the court has permitted the plaintiffs in the Fadem action to dismiss Mr. Fadem as a party-plaintiff and to add the Plumbers and Pipefitters Local 572 Pension Fund as a party-plaintiff. The two complaints generally allege that our directors and officers breached fiduciary duties owed to our shareholders in connection with the merger. On or about December 14, 2005, our litigation counsel received a letter from plaintiffs’ counsel in the Fadem action that also purported to identify areas of concern regarding our disclosures in the Definitive Proxy Statement. We believe that our disclosures are complete and that the claims are without merit. On January 12, 2006, a hearing was held to consider the plaintiffs’ motion for expedited discovery and our motion for a protective order staying all discovery. The court denied the plaintiffs’ motion and granted our motion for protective order. The court also stated that it would deny a motion by plaintiffs for injunctive relief.

 

Adelphia and Charter Matters

 

As previously reported in our 2005 Form 10-K, Adelphia Communications Corporation (Adelphia) is one of Scientific-Atlanta’s customers. Adelphia and several members of its former management are the subjects of civil and/or criminal charges brought by the SEC and the U.S. Department of Justice (DOJ); two of Adelphia’s former senior executives were found guilty of criminal charges. One aspect of the charges concerns Adelphia’s marketing support agreement with Scientific-Atlanta in 2000 and 2001 and the manner in which Adelphia accounted for such arrangements. Adelphia has agreed to a settlement with the SEC and the DOJ.

 

The SEC and DOJ have also brought charges against former officers of Charter Communications, Inc. (Charter), another of Scientific-Atlanta’s major customers. One aspect of the charges concerns an advertising agreement between Scientific-Atlanta and Charter in 2000 and the manner in which Charter accounted for such arrangements. Four former Charter officers pled guilty to certain charges; one of whom has pled guilty to charges related to the advertising agreement. In July 2004, Charter settled all civil charges brought by the SEC.

 

The SEC and the DOJ have been examining the conduct of Scientific-Atlanta and certain officers and employees with respect to the Adelphia and Charter agreements. Scientific-Atlanta’s financial statements and statements to its own investors are not at issue. As previously disclosed, Scientific-Atlanta has reached a tentative settlement with representatives of the staff of the SEC’s Enforcement Division in connection with its investigation, which is subject to approval by the SEC. Under the proposed settlement, Scientific-Atlanta would agree, without admitting or denying the allegations, to the entry of a court order that would enjoin any violations of certain reporting provisions of the federal securities laws and to pay $20 million.

 

In connection with this investigation, Scientific-Atlanta’s Senior Vice President, Finance and Operations, Wallace Haislip, and Senior Vice President, Chief Financial Officer and Treasurer, Julian Eidson, are engaged in settlement discussions with the SEC staff concerning a non-fraud administrative cease and desist order, subject to approval by the SEC Commissioners. The individuals will continue to work for Scientific-Atlanta.

 

Scientific-Atlanta continues to cooperate with the DOJ with respect to its investigation. There can be no assurance as to the final outcome of these investigations and their effects on Scientific-Atlanta.

 

25


Personalized Media Communications Proceeding

 

As previously reported in our 2005 Form 10-K, on March 28, 2002, Personalized Media Communications, LLC (PMC) filed a patent infringement action against Scientific-Atlanta in the U.S. District Court for the Northern District of Georgia. PMC seeks an injunction and unspecified monetary damages. On August 5, 2002, we filed a motion to join Gemstar TV Guide International, Inc. (which, along with its affiliated entities, is referred to hereafter as “Gemstar”). The court granted that motion, and Gemstar was added to the case. A Markman hearing was held in February 2004. Scientific-Atlanta entered into a settlement agreement with Gemstar on June 1, 2005. On June 6, 2005, the court entered its Markman Order, and Gemstar filed a Stipulation of Dismissal informing the court of the settlement and asking the court to dismiss Gemstar’s claims against Scientific-Atlanta. All of the claims asserted by PMC are in re-examination before the U.S. Patent Office. On February 6, 2006, the court issued a stay in this case and administratively closed the case until the U.S. Patent Office completes the reexamination of PMC’s patents.

 

Item 2. Changes in Securities and Use of Proceeds.

 

During the first six months of fiscal year 2006, no purchases of our common stock were made by or on behalf of Scientific-Atlanta. In February 2003, we announced a program to buy back up to 10,000,000 shares of our common stock. As of December 30, 2005, there were 7,604,700 shares available that may yet be purchased under the February 2003 stock repurchase plan.

 

26


Item 4. Submission of Matters to a Vote of Security Holders

 

The following information is furnished with respect to matters submitted to a vote of shareholders through the solicitation of proxies:

 

(a) The matters described below were submitted to a vote of shareholders at the Annual Meeting of Shareholders held on November 3, 2005.

 

  (i) Election of directors:

 

     Votes for

  

Withhold

Authority


David W. Dorman

   128,005,499    2,640,982

William E. Kassling

   126,941,375    3,705,106

Mylle H. Mangum

   120,086,798    10,559,683

 

Marion H. Antonini, James I. Cash, Jr., James H. McDonald, Terrence F. McGuirk, David J. McLaughlin, James V. Napier and Sam Nunn continue as directors.

 

  (ii) Ratification of the selection by the Audit Committee of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending June 30, 2006:

 

          For          


   Against

   Abstain

129,315,307

   202,426    1,128,748

 

  (iii) Proposal to re-approve the Senior Officer Annual Incentive Plan:

 

          For          


   Against

   Abstain

126,282,253

   2,942,929    1,421,299

 

  (iv) Proposal to adopt the 2005 Director Equity Plan for Non-Employee Directors:

 

          For          


   Against

   Abstain

82,655,858

   22,944,597    1,515,386

 

  (b) In addition after the period covered by this report, on February 2, 2006, a special meeting of the shareholders was held to consider and vote upon the approval of the Agreement and Plan of Merger, dated November 18, 2005, by and among Cisco Systems, Inc., a California corporation, Columbus Acquisition Corp., a Georgia corporation and wholly owned subsidiary of Cisco, and Scientific-Atlanta.

 

          For          


   Against

   Abstain

105,379,011

   1,395,517    1,226,515

 

Item 6. Exhibits.

 

Exhibit No.

  

Description


10.1    Senior Officer Annual Incentive Plan (filed as Appendix A to the Company’s Schedule 14A dated September 27, 2005 (Commission File No. 1-5517), and incorporated herein by reference).
10.2    2005 Equity Plan for Non-Employee Directors (filed as Appendix B to the Company’s Schedule 14A dated September 27, 2005 (Commission File No. 1-5517), and incorporated herein by reference).
31.1    Certifications of Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act.
31.2    Certifications of Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act.
32.1    Certifications of Chief Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act.
32.2    Certifications of Chief Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act.
99.1    Cautionary Statements and Risk Factors

 

27


SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

    SCIENTIFIC-ATLANTA, INC.
                    (Registrant)
Date: February 8, 2006   By:  

/s/ Julian W. Eidson


        Julian W. Eidson
        Senior Vice President,
        Chief Financial Officer and Treasurer
        (Principal Financial Officer and duly
        authorized signatory of the Registrant)

 

28